Liraglutide

Also known as: NN2211, Victoza, Saxenda

Liraglutide is a medication originally developed to treat type 2 diabetes and obesity. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs mimic the action of the GLP-1 hormone, which is naturally produced in the intestine and plays a crucial role in regulating blood sugar levels and appetite. By activating GLP-1 receptors, liraglutide helps increase insulin secretion when blood sugar levels are high, slows down gastric emptying, and reduces appetite, leading to weight loss. This dual action makes it an effective treatment for managing both di...

Potential Side Effects

Side effects score: 6; Liraglutide, a medication often used for managing type 2 diabetes and obesity, can have several side effects. Common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite. Some people may experience headaches, dizziness, or fatigue. There are also potential risks of more serious side effects, such as pancreatitis (inflammation of the pancreas)